About Avadel Pharmaceuticals
We are a biopharmaceutical company passionately committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products. We are thoughtful in our approach to identifying patient needs and finding better ways to serve them. Our organization fosters an entrepreneurial and determined atmosphere, where purpose, innovation, integrity and collaboration come together to provide new impactful treatment options for patients and their healthcare providers.
Our approach to developing new medicines is based on applying proprietary controlled-release technology that improves the way drugs are dosed and released. We are currently focused on the development and potential FDA approval of our lead candidate, FT218, for patients with narcolepsy.